Stroke Update 2009: Etiologies and Mechanisms of Ischemic Stroke

키워드

참고문헌 (53)

1. Ogata J, "Heart and vessel pathology underlying brain infarction in 142 stroke patients", Ann Neurol, 63, pp.770~781 (2008)
2. Mazighi M, "Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke", Stroke, 39, pp.1142~1147 (2008)
3. Chen XY, "Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study", Cerebrovasc Dis, 25, pp.74~80 (2008)
4. Klein IF, "Amarenco P. In vivo middle cerebral artery plaque imaging by high-resolution MRI", Neurology, 67, pp.327~329 (2006)
5. Niizuma K, "Middle cerebral artery plaque imaging using 3-Tesla high-resolution MRI", J Clin Neurosci, 15, pp.1137~1141 (2008)
6. Wang TJ, "Multiple biomarkers for the prediction of first major cardiovascular events and death", N Engl J Med, 355, pp.2631~2639 (2006)
7. Hankey GJ, "Potential new risk factors for ischemic stroke: what is their potential?", Stroke, 37, pp.2181~2188 (2006)
8. Whiteley W, "Blood biomarkers in the diagnosis of ischemic stroke: a systematic review", Stroke, 39, pp.2902~2909 (2008)
9. Laskowitz DT, "Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study", Stroke, 40, pp.77~85 (2009)
10. Dichgans M, "Genetics of ischaemic stroke", Lancet Neurol, 6, pp.149~161 (2007)
11. Rexrode KM, "Genetic variation of the androgen receptor and risk of myocardial infarction and ischemic stroke in women", Stroke, 39, pp.1590~1592 (2008)
12. Maguire JM, "Polymorphisms in platelet glycoprotein 1balpha and factor VII and risk of ischemic stroke: a meta-analysis", Stroke, 39, pp.1710~1716 (2008)
13. Bevan S, "Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5200 cases and 6600 controls", Stroke, 39, pp.1966~1971 (2008)
14. Hegele RA, "Update on the genetics of stroke and cerebrovascular disease 2007", Stroke, 39, pp.252~254 (2008)
15. Matarín M, "A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release", Lancet Neurol, 6, pp.414~420 (2007)
16. Sherva R, "A whole-genome scan for stroke or myocardial infarction in family blood pressure program families", Stroke, 39, pp.1115~1120 (2008)
17. Serena J, "Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study", Stroke, 39, pp.3131~3136 (2008)
18. Kapral MK, "Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care", CMAJ, 161, pp.989~996 (1999)
19. de Bruijn SF, "Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke", Stroke, 37, pp.2531~2534 (2006)
20. Harloff A, "Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke", Stroke, 37, pp.859~864 (2006)
21. Raff GL, "Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography", J Am Coll Cardiol, 46, pp.552~557 (2005)
22. Hur J, "Thrombus in the left atrial appendage in stroke patients: detection with cardiac CT angiography--a preliminary report", Radiology, 249, pp.81~87 (2008)
23. Kim YJ, "Patent foramen ovale: diagnosis with multidetector CT--comparison with transesophageal echocardiography", Radiology, 250, pp.61~67 (2009)
24. Hussain SI, "Comparing multislice electrocardiogram-gated spiral computerized tomography and transesophageal echocardiography in evaluating aortic atheroma in patients with acute ischemic stroke", J Stroke Cerebrovasc Dis, 17, pp.134~140 (2008)
25. Lip GY, "Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation", J Intern Med, 264, pp.50~61 (2008)
26. Douen AG, "Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke", Stroke, 39, pp.480~482 (2008)
27. Tayal AH, "Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke", Neurology, 71, pp.1696~1701 (2008)
28. Kraemer M, "Moyamoya disease in Europeans", Stroke, 39, pp.3193~3200 (2008)
29. Chiu D, "Clinical features of moyamoya disease in the United States", Stroke, 29, pp.1347~1351 (1998)
30. Hallemeier CL, "Clinical features and outcome in North American adults with moyamoya phenomenon", Stroke, 37, pp.1490~1496 (2006)
31. Kuriyama S, "Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey", Stroke, 39, pp.42~47 (2008)
32. Yoshihara T, "Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels", J Cereb Blood Flow Metab, 28, pp.1086~1089 (2008)
33. Jung KH, "Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease", J Cereb Blood Flow Metab, 28, pp.1795~1803 (2008)
34. Tohgi H, "Activated coagulation", fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels, 2000, pp.100, 373~379
35. Van Der Meer IM, "C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study", Stroke, 33, pp.2750~2755 (2002)
36. Yip HK, "Levels and value of platelet activity in patients with severe internal carotid artery stenosis", Neurology, 66, pp.804~808 (2006)
37. Zacho J, "Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease", N Engl J Med, 359, pp.1897~1908 (2008)
38. Yamada Y, "Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals", Stroke, 39, pp.2211~2218 (2008)
39. Arenillas JF, "Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis", Stroke, 39, pp.1456~1463 (2008)
40. Arenillas JF, "Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence", Stroke, 36, pp.92~97 (2005)
41. Bang OY, "Adiponectin levels in patients with intracranial atherosclerosis", Neurology, 68, pp.1931~1937 (2007)
42. Montaner J, "Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers", Stroke, 39, pp.2280~2287 (2008)
43. Kataoka S, "Activation of thrombosis and fibrinolysis following brain infarction", J Neurol Sci, 181, pp.82~88 (2000)
44. Conway DS, "Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation", Circulation, 107, pp.3141~3145 (2003)
45. Ferro D, "Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation", Arterioscler Thromb Vasc Biol, 27, pp.2763~2768 (2007)
46. Gretarsdottir S, "Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke", Ann Neurol, 64, pp.402~409 (2008)
47. Fornage M, "Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study", Stroke, 39, pp.1952~1959 (2008)
48. Kubo M, "A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction", Nat Genet, 39, pp.212~217 (2007)
49. Bevan S, "Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations", Stroke, 39, pp.1109~1114 (2008)
50. Di Tullio MR, "Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study", J Am Coll Cardiol, 52, pp.855~861 (2008)
51. Castellanos M, "Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke", Stroke, 34, pp.40~46 (2003)
52. Montaner J, "Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene", Stroke, 34, pp.2851~2855 (2003)
53. Mineharu Y, "Autosomal dominant moyamoya disease maps to chromosome 17 q25.3", Neurology, 70, pp.2357~2363 (2008)

관련 논문AI추천